Latest news with #SahajanandMedicalTechnologies
Mint
2 days ago
- Business
- Mint
Upcoming IPO: Ashish Kacholia-owned Sahajanand Medical Technologies files DRHP for public issue launch
Upcoming IPO: Medical devices company Sahajanand Medical Technologies has filed its draft red herring prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (Sebi), on Friday, July 25, 2025. Founded by Dhirajlal Kotadia in 2001, Sahajanand Medical Technologies (SMT) Limited specialises in advanced medical devices in vascular and structural heart intervention. Ashish Kacholia, Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund and Plutus Wealth Management LLP are the major shareholders in the company. According to the DRHP filing, the company is offering a book-built initial public offering (IPO) with an entirely offer for sale (OFS) component. The company proposed to make an offer-for-sale of up to 2,76,44,231 equity shares to shareholders with a face value of Re 1 apiece. The offer also provides a discounted subscription reservation for eligible employees within the employee reservation section. The public issue consists of stakes of up to 27,00,000 equity shares each of Shree Hari Trust and Dhirajkumar Savjibhai Vasoya, around 1,29,58,126 equity shares by Samara Capital Markets Holding Limited, up to 26,15,750 equity shares by Kotak Pre-IPO Opportunities Fund, and up to 66,70,355 equity shares by NHPEA Sparkle Holding B.V. The offer is conducted through a book-building process, with up to 50% allocated to qualified institutional buyers and at least 15% and 35% assigned to non-institutional and retail individual bidders, respectively, according to the draft papers. The equity shares are proposed to be listed on the NSE and BSE. The book-running lead managers for the public issue are Motilal Oswal Investment Advisors, Avendus Capital Private, HSBC Securities and Capital Markets (India), and Nuvama Wealth Management. MUFG Intime India is the registrar. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions, as market conditions can change rapidly, and circumstances may vary.
News18
2 days ago
- Business
- News18
Samara Capital-backed Sahajanand Medical Tech files IPO papers with Sebi
New Delhi, Jul 26 (PTI) Cardiac stent maker Sahajanand Medical Technologies (SMT) Ltd has filed preliminary papers with the capital markets regulator Sebi to raise funds through an initial public offering (IPO). The IPO is entirely an offer-for-sale (OFS) of 2.76 crore equity shares by promoters and investors, according to the draft red herring prospectus (DRHP) filed on Friday. Those selling shares in the public issue are Shree Hari Trust, Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund and NHPEA Sparkle Holding BV. Samara Capital Markets Holding, Kotak Pre-IPO Opportunities Fund, Plutus Wealth Management LLP, and Ashish Kacholia are major shareholders in the company. Founded in 2001, Sahajanand Medical Technologies is engaged in the development of medical devices, with an emphasis on Vascular Intervention and Structural Heart. It has two R&D centres, one in India and another in Thailand. Additionally, it has built an intellectual property portfolio, with 102 patents granted globally, 71 more patent applications in the pipeline, and five design registrations in India. The company's revenue from operations increased by 13.67 per cent to Rs 1,025 crore in fiscal 2025 from Rs 902 crore in the preceding fiscal. Its profit stood at Rs 25 crore compared to a loss of Rs 7.35 crore. Motilal Oswal Investment Advisors, Avendus Capital, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management are the book-running lead managers. Earlier, the company had filed draft papers with Sebi in September 2021 for raising Rs 1,500 crore through its IPO. This comprised fresh issuance as well as OFS. However, Sahajanand Medical Technologies didn't go ahead with the public issue. PTI SP BAL BAL view comments First Published: July 26, 2025, 16:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
